Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957

Watchlist Manager
Yunnan Botanee Bio-Technology Group Co Ltd Logo
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Watchlist
Price: 45.56 CNY 0.29%
Market Cap: 19.3B CNY
Have any thoughts about
Yunnan Botanee Bio-Technology Group Co Ltd?
Write Note

Net Margin
Yunnan Botanee Bio-Technology Group Co Ltd

13.3%
Current
19%
Average
3.3%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
13.3%
=
Net Income
790.6m
/
Revenue
6B

Net Margin Across Competitors

Country CN
Market Cap 19.1B CNY
Net Margin
13%
Country FR
Market Cap 181.7B EUR
Net Margin
15%
Country UK
Market Cap 114.1B GBP
Net Margin
11%
Country IN
Market Cap 5.5T INR
Net Margin
17%
Country UK
Market Cap 34.9B GBP
Net Margin
11%
Country DE
Market Cap 27.8B EUR
Net Margin
8%
Country US
Market Cap 27B USD
Net Margin
1%
Country JP
Market Cap 3T JPY
Net Margin
5%
Country IN
Market Cap 1.1T INR
Net Margin
-3%
Country IN
Market Cap 903.7B INR
Net Margin
14%
Country US
Market Cap 9.9B USD
Net Margin
12%
No Stocks Found

Yunnan Botanee Bio-Technology Group Co Ltd
Glance View

Market Cap
19.1B CNY
Industry
Consumer products

In the lush landscape of China's Yunnan province, Yunnan Botanee Bio-Technology Group Co Ltd has emerged as a formidable player in the skincare and beauty industry. This company, with its roots deeply intertwined with the rich biodiversity of the region, focuses on harnessing the natural bounty of botanicals to develop innovative skincare solutions. Their expertise lies in transforming these local plant resources into high-value products, capitalizing on the growing global demand for natural and organic ingredients. Each product is a testament to the company's commitment to sustainability and scientific innovation, appealing to a modern consumer base increasingly conscious about the origins and effectiveness of their skincare products. The company’s business model effectively capitalizes on both upstream and downstream processes in the beauty value chain. By controlling the entire journey from plant cultivation to product formulation and final marketing, Yunnan Botanee ensures quality and authenticity at every stage. Their flagship brand, Winona, has carved out a niche in the sensitive skin category, leveraging cutting-edge dermatological research and traditional Chinese herbal knowledge. This strategic positioning, along with strong direct-to-consumer sales combined with an omnichannel retail strategy, bolsters its revenue streams and enhances brand loyalty. Through this integrated approach, the company not only rides the wave of clean beauty trends but also sets a benchmark for sustainable growth in the industry.

Intrinsic Value
69.58 CNY
Undervaluation 35%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
13.3%
=
Net Income
790.6m
/
Revenue
6B
What is the Net Margin of Yunnan Botanee Bio-Technology Group Co Ltd?

Based on Yunnan Botanee Bio-Technology Group Co Ltd's most recent financial statements, the company has Net Margin of 13.3%.